ARCHIVES

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation

August 29, 2014

Possible Breach of Patient Confidentially By Calif. Physician; NCI

May 6, 1994

In Brief: HHS Implements Debarment Regulations; Joftes, Cain Head New NCI contract, Grants Branches

October 24, 1980

NCI Provides $40 Million To Four Centers For Cancer Communications Research.

June 27, 2003

Recision, 1981 Budget Threats Hangover NCI

March 14, 1980

Why Did DeVita Resign MSK Post? Clash Of Style, Other Serious Issues Pointed To By Colleagues

June 7, 1991